EVARISE Trademark
Trademark Overview
On Monday, November 19, 2001, a trademark application was filed for EVARISE with the United States Patent and Trademark Office. The USPTO has given the EVARISE trademark a serial number of 76340778. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, April 2, 2004. This trademark is owned by Pfizer Inc.. The EVARISE trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations
General Information
Serial Number | 76340778 |
Word Mark | EVARISE |
Filing Date | Monday, November 19, 2001 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Friday, April 2, 2004 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, July 9, 2002 |
Trademark Statements
Goods and Services | Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations |
Pseudo Mark | EVA RISE |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, December 5, 2001 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Pfizer Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10017 |
Party Name | Pfizer Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10017 |
Trademark Events
Event Date | Event Description |
Thursday, July 8, 2004 | ABANDONMENT - NO USE STATEMENT FILED |
Monday, October 27, 2003 | EXTENSION 2 GRANTED |
Thursday, September 25, 2003 | EXTENSION 2 FILED |
Sunday, June 1, 2003 | EXTENSION 1 GRANTED |
Tuesday, April 1, 2003 | EXTENSION 1 FILED |
Thursday, September 25, 2003 | PAPER RECEIVED |
Monday, September 15, 2003 | PETITION TO REVIVE-GRANTED |
Thursday, June 12, 2003 | PETITION TO REVIVE-RECEIVED |
Tuesday, July 15, 2003 | ABANDONMENT - NO USE STATEMENT FILED |
Thursday, June 12, 2003 | PAPER RECEIVED |
Tuesday, October 1, 2002 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, July 9, 2002 | PUBLISHED FOR OPPOSITION |
Wednesday, June 19, 2002 | NOTICE OF PUBLICATION |
Tuesday, February 19, 2002 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, February 7, 2002 | ASSIGNED TO EXAMINER |
Tuesday, February 5, 2002 | ASSIGNED TO EXAMINER |